Hydrofluoric Acid Inhalational Injury: Pulmonary Pathophysiology
Hydrofluoric acid (HF) inhalation causes severe chemical pneumonitis that can rapidly progress to life-threatening acute respiratory distress syndrome (ARDS), with the unique added danger of systemic fluoride toxicity causing hypocalcemia, electrolyte disturbances, and potential cardiac arrhythmias.
Mechanism of Lung Injury
HF inhalation produces a dual injury pattern that distinguishes it from typical smoke inhalation:
Direct Chemical Pneumonitis
- Corrosive damage: HF penetrates deep into lung tissue, causing direct cellular destruction of alveolar epithelium and capillary endothelium 1, 2
- Protein denaturation: The acid denatures structural proteins in lung tissue, leading to alveolar collapse and impaired gas exchange
- Inflammatory cascade: Massive inflammatory response with pulmonary edema formation that is often disproportionate to the apparent exposure 1
Systemic Fluoride Toxicity
The fluoride ion dissociates and is rapidly absorbed through damaged alveolar membranes, causing:
- Hypocalcemia and hypomagnesemia: Fluoride binds calcium and magnesium, creating life-threatening electrolyte derangements 3, 4
- Cellular enzyme dysfunction: Fluoride inhibits multiple cellular enzymes, particularly affecting cardiac and renal function
- Metabolic acidosis: From cellular dysfunction and lactate accumulation
Clinical Progression Pattern
Early Phase (0-24 hours)
- Respiratory irritation symptoms: cough, dyspnea, sore throat 2, 5
- Hypoxemia often develops rapidly and may be severe despite initially normal chest imaging
- Elevated white blood cell count is common 2
- Critical warning sign: Respiratory failure that progresses faster than typical smoke inhalation suggests HF exposure 1
Acute Phase (24-72 hours)
- Chemical pneumonitis with diffuse pulmonary infiltrates on CT imaging 3, 2
- Progression to severe ARDS requiring mechanical ventilation 1, 3
- Acute kidney injury from fluoride toxicity 3
- Risk of distributive shock 3
Severe Complications
Recent case reports demonstrate the catastrophic potential:
- Rapidly progressive respiratory failure requiring ECMO support, with mortality even despite maximal therapy 1
- Persistent pulmonary impairment in survivors, with prolonged mechanical ventilation requirements 1
- Development of rare chronic conditions including pulmonary alveolar proteinosis with chronic exposure 6
Key Diagnostic Indicators
Watch for these specific findings that suggest HF rather than simple smoke inhalation:
- Disproportionate hypoxemia: Oxygen requirements exceed what chest imaging would predict
- Rapid deterioration: Faster progression than typical inhalation injury timeline
- Biochemical markers: Hypocalcemia, hypomagnesemia, elevated fluoride levels (when available) 3, 4
- CT findings: Diffuse ground-glass opacities and consolidation representing chemical pneumonitis 3, 2
Critical Clinical Pitfall
The most dangerous error is underestimating severity based on initial presentation. Patients may appear relatively stable initially but deteriorate catastrophically within hours. The combination of pulmonary injury plus systemic fluoride toxicity creates a uniquely dangerous clinical scenario requiring immediate aggressive intervention including continuous calcium monitoring and replacement, consideration for early ECMO in severe cases, and continuous renal replacement therapy for fluoride elimination 3.
The evidence from recent case series 1, 3, 2 consistently demonstrates that HF inhalation injury has higher mortality and morbidity than standard thermal or smoke inhalation injuries, particularly when exposure occurs in enclosed spaces where gas concentrations are highest.